01/14/2025
3:16 PM | CG Oncology (Issuer)
POST LEONARD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
5:03 PM | CG Oncology (Issuer)
Song Hong Fang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
11:15 PM | CG Oncology (Filer)
| Form EFFECT | |
12/11/2024
3:09 PM | CG Oncology (Filer)
| Form S-1/A | |
12/11/2024
5:06 AM | CG Oncology (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/06/2024
5:51 PM | CG Oncology (Issuer)
POST LEONARD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
6:52 AM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
1:30 PM | CG Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
9:22 AM | CG Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/22/2024
5:06 PM | BlackRock, Inc. (Filed by)
CG Oncology (Subject)
| Form SC 13G | |
10/08/2024
8:29 AM | CG Oncology (Issuer)
Roche Corleen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CGON and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CG Oncology and its competitors with MarketBeat's FREE daily newsletter. |
10/07/2024
4:17 PM | CG Oncology (Issuer)
POST LEONARD E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
3:51 PM | CG Oncology (Issuer)
Kuan Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
3:56 PM | CG Oncology (Issuer)
Patterson Joshua F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:00 PM | Bellete Ambaw (Reporting)
CG Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:00 PM | CG Oncology (Issuer)
Mulay James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:03 PM | CG Oncology (Issuer)
Song Hong Fang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:07 PM | CG Oncology (Issuer)
Kasturi Vijay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:07 PM | CG Oncology (Issuer)
Tong Victor Edward Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:08 PM | CG Oncology (Issuer)
Liu Brian Guan-Chyun (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/07/2024
4:09 PM | CG Oncology (Issuer)
Graf Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
6:18 PM | CG Oncology (Issuer)
Song Hong Fang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
7:26 PM | CG Oncology (Subject)
Charming Jade Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
7:27 PM | CG Oncology (Subject)
Unique Diamond Investments Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
5:43 PM | CG Oncology (Subject)
Charming Jade Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
5:44 PM | CG Oncology (Subject)
Unique Diamond Investments Ltd (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
5:19 AM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
5:19 AM | CG Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/22/2024
3:35 PM | CG Oncology (Subject)
Unique Diamond Investments Ltd (Filed by)
| Form SC 13G | |
05/24/2024
7:15 AM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
5:57 PM | CG Oncology (Issuer)
Patterson Joshua F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
4:11 PM | CG Oncology (Issuer)
Patterson Joshua F. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/09/2024
7:10 AM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
5:07 AM | CG Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024
6:08 PM | CG Oncology (Issuer)
Cui Xiangmin (Reporting)
Decheng Capital Global Healthcare Fund , LP (0001949026) (Reporting)
Decheng Capital Global Healthcare GP, LLC (Reporting)
Decheng Capital Global Life Sciences Fund IV, L.P. (Reporting)
| Form 4/A | |
04/09/2024
6:12 PM | CG Oncology (Subject)
Decheng Capital Global Life Sciences Fund IV, L.P. (Filed by)
| Form SC 13G/A | |
03/26/2024
5:05 AM | CG Oncology (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
6:25 PM | CG Oncology (Subject)
Kissei Pharmaceutical Co., Ltd. (Filed by)
| Form SC 13G | |
02/16/2024
3:21 PM | CG Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
3:31 PM | CG Oncology (Subject)
TCG Crossover GP I, LLC (Filed by)
| Form SC 13G | |
02/08/2024
4:17 PM | CG Oncology (Subject)
Decheng Capital Global Life Sciences Fund IV, L.P. (Filed by)
| Form SC 13G | |
Elon’s #1 AI Stock” SET TO SOAR (Ad) Forget ChatGPT!
Because Elon Musk's AI promises to be 100x more powerful. Get all the details here >>> |
02/05/2024
3:40 PM | CG Oncology (Subject)
Longitude Capital Partners IV, LLC (Filed by)
| Form SC 13G | |
02/05/2024
2:15 PM | CG Oncology (Subject)
Foresite Capital Fund V, L.P. (Filed by)
| Form SC 13G | |
01/31/2024
3:30 PM | CG Oncology (Issuer)
Song Hong Fang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:30 PM | CG Oncology (Issuer)
Roche Corleen M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:30 PM | CG Oncology (Issuer)
Kasturi Vijay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
